Clinical Trial Highlights

• TAVI Improves QoL in Patients Suitable for Transfemoral TAVI
• Results from the PARTNER Trial (Cohort A): Transfemoral TAVI Economically Attractive but Transapical TAVI More Costly
• PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years
• Transapical TAVI Inferior to SAVR in Operable Elderly Patients
• Primary Results of ADVISE: Validation of a Vasodilator Independent Measure of Coronary Fractional Flow Reserve
• Point-of-Care Genetic Testing Facilitates Rapid Personalization of Antiplatelet Therapy
• Bioabsorbable Polymer Stent Noninferior to Permanent Polymer Stent
• BRIDGE Study Demonstrates Feasibility and Safety of Cangrelor